20results about "Nose implants" patented technology

Patient-specific, pre-molded, implantable epithesis holder (1), made of a biocompatible, artifact-free or low-artifact material, such as a plastic or a ceramic, wherein the epithesis holder (1) has at least one attachment point (6, 6.1, 6.2) for attaching it to a patient's own support structure, such as a bone structure, and first connection means (4, 4.1) to which an external epithesis (8) equipped with second connection means complementary to the first connection means (4, 4.1) is held when placed in intervention with the first connection means (4, 4.1).

The present invention relates to materials, devices, kits and methods for use in treatment of patients having a sinus condition such as severe chronic rhinosinusitis. The implant configured to fit ins

A nasal implant comprises an implant body comprising a distal end, a proximal end, a central portion disposed between the proximal end and the distal end, a core made of a degradable material, and a coating on an outer surface of the implant core. The central portion comprises a plurality of ribs. The coating comprises hydrophobic material which is bioabsorbable, wherein the coating and the implant core do not deliver a pharmaceutical agent or a drug. The nasal implant further comprises a first arm disposed at the distal end, the first arm having a proximal end fixed to the body and a distal end not fixed to the body, and a second arm having a proximal end fixed to the body and a distal end not fixed to the body. The distal end of the first arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration. The distal end of the second arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration, wherein the first and second arms are biased toward their deployed configuration.

The present disclosure relates to a nasal cavity memory stent and a deformable nasal cavity support system, the stent body is formed by a shape memory wire having a first shape and a second shape at different temperatures, in the second shape, the shape memory wire is in a spiral structure to be used for nasal cavity packing and support to improve nasal ventilation by a spring-like structure. When needed, the stent body is only needed to be inserted into the nasal cavity, and the inserted stent body can be gradually deformed to fit the inner wall of the nasal cavity to support the nasal cavity by the temperature of the nasal cavity. When disassembled, the stent outer end is only needed to be cooled, and the initial shape can be gradually recovered from the outer end to be removed from the nasal cavity. The deformable nasal cavity support system can be used for postoperative nasal cavity packing of nasal septum correction surgery, nasal endoscopy and the like, and can also be used for improving hypoxia caused by adenoid hypertrophy blocking the posterior naris and improving the obstruction of the oropharynx of patients with obstructive sleep apnea hypopnea, smooth breathing and sleep aid.

A septum support or nasal splint that is insertable within a nasal cavity of a patient to maintain a position of a septum of the patient includes a base and a first side member that is positioned on a first side of the base and that extends upward from the base. The first side member is configured to contact the septum of the nasal cavity. The septum support also includes a second side member that is positioned on a second side of the base and that extends upward from the base. The second side member is configured to contact a turbinate of the nasal cavity so as to reinforce the first side member. A lower end of the second side member is securely connected to the base or first side member and an upper end of the second side member is not attached to the first side member.

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis. An implant is configured to fit inside of the middle meatus of a human nasal cavity. The implant includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate. The implant releases the mometasone furoate for more than 12 weeks. A second implant can also be provided configured to fit inside the middle meatus. The second implant also includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate, and releases the mometasone furoate for more than 12 weeks.

This application discloses a nasal implant processing apparatus, relating to the field of nasal implant processing. It includes a base, a support ring, a first rotating ring, and a second rotating ring. The support ring is fixedly mounted on the base. The first rotating ring is coaxially rotatably mounted on the support ring. Three clamping components are slidably arranged at intervals along the circumference of the first rotating ring, with their close-to-each ends clamping and limiting the nasal implant. The second rotating ring is coaxially rotatably mounted on the support ring, and a support component is mounted on the second rotating ring. The support end of the support component abuts and supports the opposite side of the nasal implant to be processed. This application uses three clamping components to clamp and limit the nasal implant, combined with the support component to abut and support the nasal implant, making it less prone to shaking during processing and carving, thus improving the processing accuracy of the nasal implant. By rotating the first rotating ring, the nasal implant can be rotated and adjusted without releasing the clamping and limiting state, thereby improving the processing efficiency of the nasal implant.

The invention discloses a bionic rhinoplasty stent, and relates to the technical field of rhinoplasty, the rhinoplasty stent comprises a nasal columella area and a nasal septum clamping area connected with the nasal columella area, and the nasal columella area is located in front of the nasal septum clamping area; the columella nasi area comprises a columella nasi main body, the left side and the right side of the columella nasi main body are both connected with outer side foot supporting parts, the columella nasi main body and the outer side foot supporting parts are of an integrated structure, and the nasal septum clamping area comprises two nasal septum clamping pieces connected with the columella nasi main body; the nasal columella main body and the outer side foot supporting part are integrally arranged, so that the rhinoplasty stent does not need to be set up and sutured, an autologous tissue does not need to be additionally used for nose tip heightening, suturing and fixing, the stent can be directly adopted, the rhinoplasty difficulty is reduced, the time needed by rhinoplasty is shortened, and the rhinoplasty efficiency is improved. The problems that due to the fact that the outer side foot support and the fornix supporting portion support are sutured respectively, the nose tip portion is loosened and displaced, the nose tip rotates up and down, and the beauty seeker needs to be operated again are solved, and the pain of the beauty seeker in the rhinoplasty operation is relieved.

An implantable scaffold device comprises a non-biodegradable backbone and a biodegradable dermal compartment comprising live cells. Method of fabricating implantable devices via 3D printing using a synthetic ink formulation coprinted with a biodegradable bioink.

Systems and methods for deploying a stent within the frontal sinus. The stent includes flexible foam and film layers arranged in a stacked configuration and furled within a cartridge prior to deployment. The cartridge is removably coupled to an applicator device including an actuator. The film layer may include a polymer having a resilience sufficient to unfurl the stent and maintain patency of the frontal sinus opening. The flexible foam layer may have porosity of greater than 80%, and an active agent may be within the flexible foam layer. The flexible foam layer may be bioresorbable and the flexible film layer biocompatible and non-biodegradable. The stent may include first and second body portions with the first body portion independently unfurling from the second body portion to retain the stent within the frontal sinus. Contouring of the first and second body portions may facilitate ease with removal of the stent.

A septum support or nasal splint that is insertable within a nasal cavity of a patient to maintain a position of a septum of the patient includes a base and a first side member that is positioned on a first side of the base and that extends upward from the base. The first side member is configured to contact the septum of the nasal cavity. The septum support also includes a second side member that is positioned on a second side of the base and that extends upward from the base. The second side member is configured to contact a turbinate of the nasal cavity so as to reinforce the first side member. A lower end of the second side member is securely connected to the base or first side member and an upper end of the second side member is not attached to the first side member.

A nasal implant comprises an implant body comprising a distal end, a proximal end, a central portion disposed between the proximal end and the distal end, a core made of a degradable material, and a coating on an outer surface of the implant core. The central portion comprises a plurality of ribs. The coating comprises hydrophobic material which is bioabsorbable, wherein the coating and the implant core do not deliver a pharmaceutical agent or a drug. The nasal implant further comprises a first arm disposed at the distal end, the first arm having a proximal end fixed to the body and a distal end not fixed to the body, and a second arm having a proximal end fixed to the body and a distal end not fixed to the body. The distal end of the first arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration. The distal end of the second arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration, wherein the first and second arms are biased toward their deployed configuration.

The invention related to an implant comprising a scaffold comprising at least one first area characterized by micropores and at least one second area characterized by macropores, wherein said at least one second area is defined by being expected to be exposed to higher pressures and / or forces when compared with said at least one first area, and methods thereof.

A nasal valve implant delivery system includes a delivery tool having a handle having a proximal end and a distal end, wherein a longitudinal axis extends in a direction between the proximal end and the distal end. The system further includes a needle extending from the distal end of the handle, wherein the needle is movable relative to the handle along the longitudinal axis of the handle.. The system further includes a pusher member disposed partially within a lumen of the needle, wherein the pusher member is configured to push an implant disposed in the lumen of the needle. The system further includes a light source and a moveable needle shuttle disposed in the handle and coupled to the needle. The system further includes one or more springs coupled to the moveable needle shuttle, wherein the one or more springs are configured to apply a proximal tensioning force on the moveable needle shuttle and an actuator configured to releaseably engage with the moveable needle shuttle, wherein the actuator is configured to be actuated to release the moveable needle shuttle from the actuator such that the moveable needle shuttle moves the needle proximally, which (i) retracts the needle proximally at least partially into the handle and and (ii) deploys the implant from a distal tip of the needle.

The present disclosure relates to a medical device having irregular and / or curved silicone surfaces, wherein at least a part of the irregular and / or curved silicone surfaces is coated with rhamnolipids. The present disclosure also relates to a method of coating a medical device having irregular and / or curved silicone surfaces with rhamnolipids, wherein the method comprises the steps of 1) activating the silicone surfaces that are to be coated by introducing free amino-groups; and 2) covalently attaching rhamnolipids to said silicone surfaces. The present disclosure also relates to a voice prosthesis, for mounting in a fistula between trachea and esophagus, wherein at least a part of the voice prosthesis comprises silicone and at least a part of said silicone being coated with rhamnolipids.

An implant for a sinus cavity that can have a main body portion and a second body portion coupled with the main body portion. In some embodiments, the second body portion can extend at an angle away from the main body portion. The implant can be sized and configured for implantation in the frontal sinus. A size and a shape of the implant can be similar to a size and a shape of the frontal sinus of a patient that the implant will be implanted into.WO

A rhinological implant (10) for straightening the nasal septum, which can be fastened to an outer surface of the septum and is made from a flat blank provided with several continuous perforations (15), is characterized in that it has a flat shape and, in the implanted state, lies flatly over its entire surface on only one of the two outer surfaces of the septum; has a triangular base body (11), in which, starting from a triangle vertex (S), two catheti edges (12a, 13a) are arranged at a triangular angle (φ) relative to one another, lead straight away from the triangle vertex and on both sides each run in the direction of a hypotenuse edge (14a) opposite the triangle vertex;and that the triangular base body is extended at both cathetial edges by two side sections (12, 13), each extending from the triangle apex beyond the hypotenuse edge, with the outer edges (12a', 13a') of the two side sections each running in alignment with a cathetial edge. The device is not erected from a flat blank into a three-dimensional shape and placed over the part of the septum on the nasal bridge side, but rather allows for one-sided application on a side surface of the septum. The manufacturing effort is significantly reduced, and considerable material and weight are saved.

Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and / or delivery of the implant.